Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peposertib with Capecitabine and RT in Locally Advanced Rectal Cancer
NCT03770689Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Mar 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of peposertib in rectal cancer, sponsored by EMD Serono. Started Mar 2019; status: completed.
02
Drugs
peposertib
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03770689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770689.